Clinical Trials Sponsored by Takeda Pharmaceuticals Company Limited

Total 217 results

Hanmi Pharmaceutical Company Limited

Not yet recruiting

A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Recruiting

Dose Escalation and Expansion Study of BH3120 in Advanced or Metastatic Solid Tumors

Advanced or Metastatic Solid Tumors

Korea, Republic of, United States
Hanmi Pharmaceutical Company Limited

Recruiting

Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors

Advanced or Metastatic Solid Tumors

Korea, Republic of, Australia
Hanmi Pharmaceutical Company Limited

Recruiting

Phase 2 Study to Assess the Safety, PK, and PD in SBS-IF Subjects

Short Bowel Syndrome

Belgium, Korea, Republic of, United States, Germany, Denmark, France, Poland
Hanmi Pharmaceutical Company Limited

Completed

Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP1802 to HGP1705 in Healthy Volunteers

Healthy Volunteer

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP2105 to RLD2104 in Healthy Volunteers

Healthy Volunteer

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

A Study to Evaluate Efficacy and Safety of HCP1803 in Patients With Essential Hypertension (HM_APOLLO)

Hypertension

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

A Study to Evaluate the Drug-drug Interaction and Safety of RLD2301 and RLD2007 in Healthy Volunteers

Healthy Volunteers

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

A Study to Evaluate the PK, Safety and Tolerability of HCP1803.

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Safety to Evaluate the Efficacy and Safety of HIP1601 in Patients With Non Erosive Reflux Disease

Non-erosive Gastroesphageal Reflux Disease

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

An Observational Study to Evaluate Effectiveness and Safety of Amosartan Plus Tablet

Hypertension,Essential

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension (HM_APOLLO)

Hypertension

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

A First-in-Human, Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15136 in Healthy Subjects

Pharmacology

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Poziotinib in Patients With HER2+ Recurrent Stage IV BC Who Have Received at Least 2 Prior HER2-directed Regimens

Metastatic Breast Cancer

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Observational Study to Evaluate Therapeutic Effectiveness and Safety of Monterizine Cap.

Asthma | Perennial Allergic Rhinitis

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

A Study of Multiple Doses of HM15211 in Obese Subjects With NAFLD

NAFLD

United States
Hanmi Pharmaceutical Company Limited

Completed

Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in Korea

Dyslipidemias

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Terminated

Multiple Ascending Dose Study of HM12460A in Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States
Hanmi Pharmaceutical Company Limited

Terminated

Phase II Trial of HM61713 for the Treatment of ≥2nd Line T790M Mutation Positive Adenocarcinoma of the Lung

Non Small Cell Lung Cancer

United States, Australia, Italy, Korea, Republic of, Spain, Germany, Malaysia, Taiwan, Canada, Philippines
Hanmi Pharmaceutical Company Limited

Completed

Efficacy and Safety of HIP1601 Capsule

Erosive Gastroesophageal Reflux Disease

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Molar Potency Study of HM12460A in Healthy Subjects

Healthy Volunteers

United States
Hanmi Pharmaceutical Company Limited

Terminated

Olmutinib 600 mg QD in Patients With T790M-positive NSCLC After Treatment With an EGFR-TKI

Non Small Cell Lung Cancer

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Unknown

Clinical Trial to Assess the Efficacy and Safety of MUCOLASE Tablet(Streptokinase • Streptodornase)

Acute Upper Respiratory Infection | Acute Bronchitis

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HGP1602 in Healthy Subjects

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

A Study to Evaluate the Pharmacokinetics and Safety of HCP1704 in Healthy Subjects

Health, Subjective

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

A Study to Evaluate the Pharmacokinetic and Pharmacodynamic Interactions Between HGP0904, HGP0608, and HCP1306 in Healthy Male Subjects.

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Phase II Trial to Evaluate the Efficacy and Safety of HM61713 as the 1st-line NSCLC Anticancer Therapy

Non Small Cell Lung Cancer

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Unknown

Safety, Pharmacokinetics and Pharmacodynamics of the Two Esomeprazole Formulations

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Unknown

Safety and Efficacy Study of HGP1207 in Patients With Pulmonary Hypertension

Pulmonary Hypertension | Systolic Dysfunction

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Evaluating the Bioequivalence of HIP1403 and HGP0919 Suspensions

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Pharmacokinetics and Safety of HCP1105 and Co-administration of HGP0918, HGP0816 in Healthy Male Volunteers

Hyperlipidemias

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Clinical Efficacy and Safety Evaluation of Co-administered HGP0904, HGP0608 and HGP0816 in Patients With Hypertension and Dyslipidemia

Hypertension | Hyperlipidemia

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605

Hypertension

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Evaluating the Bioequivalence of HIP1403, HGP0919

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Investigating the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Pharmacokinetics of Sildenafil Following Administration of an Chewable Tablet of Sildenafil Relative to Viagra® Conventional Oral Tablet in Healthy Volunteers

Erectile Dysfunction

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Effect of LAPS-Exendin on Body Weight in Obese Population

Obesity

United States
Hanmi Pharmaceutical Company Limited

Completed

Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes

Type 2 Diabetes

United States
Hanmi Pharmaceutical Company Limited

Completed

Glycaemic Control of Monthly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes

Type 2 Diabetes

United States
Hanmi Pharmaceutical Company Limited

Completed

PK and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 Under Fed Condition in Healthy Male Volunteers

Prostatic Hyperplasia | Erectile Dysfunction
Hanmi Pharmaceutical Company Limited

Completed

Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male Volunteers

Prostatic Hyperplasia | Erectile Dysfunction

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Safety and Efficacy Study of Recombinant Human Growth Hormone in Adult Growth Hormone Deficiency Patients (HM10560A)

Adult Growth Hormone Deficiency

Hungary
Hanmi Pharmaceutical Company Limited

Completed

Efficacy/Safety of HCP1306 Tablet Versus HGP0816 Tablet in Patients With Primary Hypercholesterolemia

Primary Hypercholesterolemia

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Evaluating a Pharmacokinetic Drug Interaction Between HGP0918 and HGP0816

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Efficacy and Safety of HCP1102 Capsule

Asthma With Allergic Rhinitis

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Unknown

Evaluating the Efficacy and Safety of HCP1105 in Combined Hyperlipidemic Patients With High Risk for CHD

Hyperlipidemias

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Safety,PK/PD, Food Effect Study of Orally Administered HM71224 in Healthy Adult Male Volunteers

Rheumatoid Arthritis

Netherlands
Hanmi Pharmaceutical Company Limited

Unknown

A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors

Breast Cancer | Gastric Cancer | Unspecified Adult Solid Tumor, Protocol Specific

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and Tamsulosin

Benign Prostatic Hyperplasia | Erectile Dysfunction

Korea, Republic of

Clinical Trials Sponsored by Takeda Pharmaceuticals Company Limited

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations